A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial.
- Simon Hyttel-Sorensen
- , Topun Austin
- , Frank van Bel
- , Manon Benders
- , Olivier Claris
- , Eugene Dempsey
- , Monica Fumagalli
- , Gorm Greisen
- , Berit Grevstad
- , Cornelia Hagmann
- , Lena Hellström-Westas
- , Petra Lemmers
- , Jane Lindschou
- , Gunnar Naulaers
- , Wim van Oeveren
- , Adelina Pellicer
- , Gerhard Pichler
- , Claudia Roll
- , Maria Skoog
- , Per Winkel
Research output: Contribution to journal › Article › peer-review